Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Development of small molecule HIV-1 fusion inhibitors: linking biology to chemistry.

Miyamoto F, Kodama EN.

Curr Pharm Des. 2013;19(10):1827-34. Review.

PMID:
23092276
2.

Synthesized peptide inhibitors of HIV-1 gp41-dependent membrane fusion.

He Y.

Curr Pharm Des. 2013;19(10):1800-9. Review.

PMID:
23092277
3.

Development of HIV-1 fusion inhibitors targeting gp41.

Lu K, Asyifah MR, Shao F, Zhang D.

Curr Med Chem. 2014 Jun;21(17):1976-96. Review.

PMID:
24350848
4.

Peptide and non-peptide HIV fusion inhibitors.

Jiang S, Zhao Q, Debnath AK.

Curr Pharm Des. 2002;8(8):563-80. Review.

PMID:
11945159
5.

The current status and challenges in the development of fusion inhibitors as therapeutics for HIV-1 infection.

Tan JJ, Ma XT, Liu C, Zhang XY, Wang CX.

Curr Pharm Des. 2013;19(10):1810-7. Review.

PMID:
23092283
6.

[The current progress in the development of HIV-1 fusion inhibitors].

Shi WG, Jia QY, Liu KL.

Yao Xue Xue Bao. 2010 Feb;45(2):184-93. Review. Chinese.

PMID:
21351428
8.

HIV-1 gp41: mediator of fusion and target for inhibition.

Weiss CD.

AIDS Rev. 2003 Oct-Dec;5(4):214-21. Review.

PMID:
15012000
9.

Discovery of small molecule fusion inhibitors targeting HIV-1 gp41.

Zhou G, Chu S.

Curr Pharm Des. 2013;19(10):1818-26. Review.

PMID:
23092284
10.

Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket.

Yu F, Lu L, Du L, Zhu X, Debnath AK, Jiang S.

Viruses. 2013 Jan 11;5(1):127-49. doi: 10.3390/v5010127. Review.

11.

Development of peptide and small-molecule HIV-1 fusion inhibitors that target gp41.

Cai L, Jiang S.

ChemMedChem. 2010 Nov 8;5(11):1813-24. doi: 10.1002/cmdc.201000289. Review.

PMID:
20845360
12.

HIV entry and fusion inhibitors.

Chantry D.

Expert Opin Emerg Drugs. 2004 May;9(1):1-7. Review.

PMID:
15155132
13.

HIV fusion inhibitors.

Qadir MI, Malik SA.

Rev Med Virol. 2010 Jan;20(1):23-33. doi: 10.1002/rmv.631. Review.

PMID:
19827030
14.

Updating the use of synthetic peptides as inhibitors of HIV-1 entry.

Gómara MJ, Haro I.

Curr Med Chem. 2014 Apr;21(10):1188-200. Review.

PMID:
23931277
15.

Novel therapies based on mechanisms of HIV-1 cell entry.

Kilby JM, Eron JJ.

N Engl J Med. 2003 May 29;348(22):2228-38. Review. No abstract available.

PMID:
12773651
16.
17.

Novel HIV-1 fusion inhibition peptides: designing the next generation of drugs.

Miyamoto F, Kodama EN.

Antivir Chem Chemother. 2012 Jan 17;22(4):151-8. doi: 10.3851/IMP1930. Review.

PMID:
22182762
18.

HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds.

Liu S, Wu S, Jiang S.

Curr Pharm Des. 2007;13(2):143-62. Review.

PMID:
17269924
19.

Peptide fusion inhibitors targeting the HIV-1 gp41: a patent review (2009 - 2014).

Zhang D, Li W, Jiang S.

Expert Opin Ther Pat. 2015 Feb;25(2):159-73. doi: 10.1517/13543776.2014.987752. Epub 2014 Nov 27. Review.

PMID:
25428639

Supplemental Content

Support Center